Cargando…

Marker assisted selection with optimised contributions of the candidates to selection

The benefits of marker assisted selection (MAS) are evaluated under realistic assumptions in schemes where the genetic contributions of the candidates to selection are optimised for maximising the rate of genetic progress while restricting the accumulation of inbreeding. MAS schemes were compared wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Villanueva, Beatriz, Pong-Wong, Ricardo, Woolliams, John A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705444/
https://www.ncbi.nlm.nih.gov/pubmed/12486398
http://dx.doi.org/10.1186/1297-9686-34-6-679
_version_ 1782169001330212864
author Villanueva, Beatriz
Pong-Wong, Ricardo
Woolliams, John A
author_facet Villanueva, Beatriz
Pong-Wong, Ricardo
Woolliams, John A
author_sort Villanueva, Beatriz
collection PubMed
description The benefits of marker assisted selection (MAS) are evaluated under realistic assumptions in schemes where the genetic contributions of the candidates to selection are optimised for maximising the rate of genetic progress while restricting the accumulation of inbreeding. MAS schemes were compared with schemes where selection is directly on the QTL (GAS or gene assisted selection) and with schemes where genotype information is not considered (PHE or phenotypic selection). A methodology for including prior information on the QTL effect in the genetic evaluation is presented and the benefits from MAS were investigated when prior information was used. The optimisation of the genetic contributions has a great impact on genetic response but the use of markers leads to only moderate extra short-term gains. Optimised PHE did as well as standard truncation GAS (i.e. with fixed contributions) in the short-term and better in the long-term. The maximum accumulated benefit from MAS over PHE was, at the most, half of the maximum benefit achieved from GAS, even with very low recombination rates between the markers and the QTL. However, the use of prior information about the QTL effects can substantially increase genetic gain, and, when the accuracy of the priors is high enough, the responses from MAS are practically as high as those obtained with direct selection on the QTL.
format Text
id pubmed-2705444
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27054442009-07-03 Marker assisted selection with optimised contributions of the candidates to selection Villanueva, Beatriz Pong-Wong, Ricardo Woolliams, John A Genet Sel Evol Research The benefits of marker assisted selection (MAS) are evaluated under realistic assumptions in schemes where the genetic contributions of the candidates to selection are optimised for maximising the rate of genetic progress while restricting the accumulation of inbreeding. MAS schemes were compared with schemes where selection is directly on the QTL (GAS or gene assisted selection) and with schemes where genotype information is not considered (PHE or phenotypic selection). A methodology for including prior information on the QTL effect in the genetic evaluation is presented and the benefits from MAS were investigated when prior information was used. The optimisation of the genetic contributions has a great impact on genetic response but the use of markers leads to only moderate extra short-term gains. Optimised PHE did as well as standard truncation GAS (i.e. with fixed contributions) in the short-term and better in the long-term. The maximum accumulated benefit from MAS over PHE was, at the most, half of the maximum benefit achieved from GAS, even with very low recombination rates between the markers and the QTL. However, the use of prior information about the QTL effects can substantially increase genetic gain, and, when the accuracy of the priors is high enough, the responses from MAS are practically as high as those obtained with direct selection on the QTL. BioMed Central 2002-11-15 /pmc/articles/PMC2705444/ /pubmed/12486398 http://dx.doi.org/10.1186/1297-9686-34-6-679 Text en Copyright © 2002 INRA, EDP Sciences
spellingShingle Research
Villanueva, Beatriz
Pong-Wong, Ricardo
Woolliams, John A
Marker assisted selection with optimised contributions of the candidates to selection
title Marker assisted selection with optimised contributions of the candidates to selection
title_full Marker assisted selection with optimised contributions of the candidates to selection
title_fullStr Marker assisted selection with optimised contributions of the candidates to selection
title_full_unstemmed Marker assisted selection with optimised contributions of the candidates to selection
title_short Marker assisted selection with optimised contributions of the candidates to selection
title_sort marker assisted selection with optimised contributions of the candidates to selection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705444/
https://www.ncbi.nlm.nih.gov/pubmed/12486398
http://dx.doi.org/10.1186/1297-9686-34-6-679
work_keys_str_mv AT villanuevabeatriz markerassistedselectionwithoptimisedcontributionsofthecandidatestoselection
AT pongwongricardo markerassistedselectionwithoptimisedcontributionsofthecandidatestoselection
AT woolliamsjohna markerassistedselectionwithoptimisedcontributionsofthecandidatestoselection